Page last updated: 2024-10-30

mesalamine and Arthritis, Post-Infectious

mesalamine has been researched along with Arthritis, Post-Infectious in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"A patient with chronic Reiter's syndrome (RS) refractory to nonsteroidal antiinflammatory therapy was prescribed mesalamine (Pentasa) therapy for a 4-month trial."1.29Mesalamine therapy in Reiter's syndrome. ( Inman, RD; McKibbon, C; Thomson, GT, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Thomson, GT1
McKibbon, C1
Inman, RD1

Other Studies

1 other study available for mesalamine and Arthritis, Post-Infectious

ArticleYear
Mesalamine therapy in Reiter's syndrome.
    The Journal of rheumatology, 1994, Volume: 21, Issue:3

    Topics: Adult; Aminosalicylic Acids; Arthritis, Reactive; Colitis; Gastroenteritis; Humans; Ileitis; Male; M

1994